CDER’s Office of Compliance highlights enforcement actions in 2023
Regulatory NewsJoanne S. Eglovitch
APIsBiologics/ biosimilars/ vaccinesBiotechnologyOTCPharmaceuticalsRegulatory NewsJoanne S. EglovitchAPIsBiologics/ biosimilars/ vaccinesBiotechnologyOTCPharmaceuticals